Total Payments
$154,103
2024 Payments
$18,940
Companies
16
Transactions
74
Medicare Patients
1,180
Medicare Billing
$152,266
Payment Breakdown by Category
Consulting$101,298 (65.7%)
Research$21,815 (14.2%)
Other$15,250 (9.9%)
Travel$7,887 (5.1%)
Royalty/License$5,000 (3.2%)
Food & Beverage$2,852 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $101,298 | 19 | 65.7% |
| Unspecified | $21,815 | 17 | 14.2% |
| Honoraria | $15,250 | 5 | 9.9% |
| Travel and Lodging | $7,887 | 9 | 5.1% |
| Royalty or License | $5,000 | 1 | 3.2% |
| Food and Beverage | $2,852 | 23 | 1.9% |
Payments by Type
General
$132,287
57 transactions
Research
$21,815
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $28,646 | 4 | $0 (2023) |
| H. Lundbeck A S | $26,663 | 12 | $0 (2024) |
| Lundbeck LLC | $17,437 | 11 | $0 (2019) |
| PTC Therapeutics, Inc. | $17,071 | 9 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $15,019 | 2 | $0 (2017) |
| Theravance Biopharma, Inc. | $14,567 | 6 | $0 (2018) |
| Biogen, Inc. | $12,270 | 8 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $5,000 | 1 | $0 (2023) |
| Eli Lilly and Company | $4,755 | 2 | $0 (2024) |
| SANOFI US SERVICES INC. | $4,246 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,940 | 20 | H. Lundbeck A S ($12,460) |
| 2023 | $12,046 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($7,046) |
| 2022 | $20,240 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($18,000) |
| 2021 | $5,425 | 2 | Eli Lilly and Company ($4,675) |
| 2020 | $3,600 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($3,600) |
| 2019 | $33,900 | 22 | H. Lundbeck A S ($13,453) |
| 2018 | $23,131 | 8 | PTC Therapeutics, Inc. ($9,500) |
| 2017 | $36,820 | 15 | AstraZeneca Pharmaceuticals LP ($15,019) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $4,246.00 | General |
| 09/29/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $80.00 | General |
| 09/25/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $70.26 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/25/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $47.33 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $119.41 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $107.88 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $29.64 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $29.64 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $27.32 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $10.69 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $9.23 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $7.56 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 09/22/2024 | Teva Pharmaceuticals USA, Inc. | — | Travel and Lodging | In-kind items and services | $579.50 | General |
| 09/22/2024 | Teva Pharmaceuticals USA, Inc. | — | — | In-kind items and services | $416.20 | Research |
| Study: TV56286-NDG-20039 | ||||||
| 07/31/2024 | Sumitomo Pharma Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 03/19/2024 | H. Lundbeck A S | — | Travel and Lodging | Cash or cash equivalent | $207.78 | General |
| 03/14/2024 | H. Lundbeck A S | — | Honoraria | Cash or cash equivalent | $6,000.00 | General |
| 02/28/2024 | H. Lundbeck A S | — | Travel and Lodging | In-kind items and services | $5,456.00 | General |
| 02/28/2024 | H. Lundbeck A S | — | Travel and Lodging | In-kind items and services | $644.00 | General |
| 02/28/2024 | H. Lundbeck A S | — | Food and Beverage | In-kind items and services | $152.00 | General |
| 09/08/2023 | Regeneron Pharmaceuticals, Inc. | — | Royalty or License | Cash or cash equivalent | $5,000.00 | General |
| 04/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $45.79 | General |
| 01/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
| 11/17/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/29/2022 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase 1 MAD | Biogen, Inc. | $5,412 | 1 |
| TV56286-NDG-20039 | Teva Pharmaceuticals USA, Inc. | $875.16 | 11 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 227 | 271 | $110,620 | $27,309 |
| 2022 | 10 | 311 | 543 | $169,880 | $45,737 |
| 2021 | 12 | 464 | 709 | $208,895 | $58,689 |
| 2020 | 7 | 178 | 196 | $109,500 | $20,530 |
Total Patients
1,180
Total Services
1,719
Medicare Billing
$152,266
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 53 | $38,160 | $8,069 | 21.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 24 | $21,600 | $4,778 | 22.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 25 | 38 | $7,600 | $4,083 | 53.7% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 26 | 26 | $24,960 | $3,612 | 14.5% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 24 | 24 | $5,640 | $2,709 | 48.0% |
| 75893 | Review by radiologist of imaging guidance for removal of blood sample | Office | 2023 | 26 | 26 | $4,620 | $2,522 | 54.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 23 | 36 | $2,700 | $1,014 | 37.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 23 | $4,080 | $306.36 | 7.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 21 | 21 | $1,260 | $215.04 | 17.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 81 | $58,320 | $13,225 | 22.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 26 | 78 | $15,600 | $8,877 | 56.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 48 | 177 | $13,050 | $5,270 | 40.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $19,800 | $4,260 | 21.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 28 | 50 | $8,750 | $4,127 | 47.2% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2022 | 26 | 26 | $28,080 | $3,707 | 13.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 26 | 26 | $7,800 | $3,150 | 40.4% |
| 75893 | Review by radiologist of imaging guidance for removal of blood sample | Office | 2022 | 24 | 24 | $4,320 | $2,410 | 55.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 29 | 30 | $7,200 | $408.02 | 5.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 28 | 29 | $6,960 | $302.35 | 4.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 71 | 89 | $64,080 | $14,930 | 23.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 49 | 49 | $44,100 | $10,018 | 22.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 70 | 244 | $18,000 | $7,471 | 41.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 20 | 48 | $9,600 | $5,865 | 61.1% |
| 93660 | Evaluation of heart function using tilt table | Office | 2021 | 34 | 35 | $10,500 | $5,196 | 49.5% |
| 75893 | Radiological supervision and interpretation of drawing blood via catheter procedure | Office | 2021 | 43 | 44 | $7,920 | $4,741 | 59.9% |
About Dr. Horacio Kaufmann, M.D
Dr. Horacio Kaufmann, M.D is a Neurology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134190291.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Horacio Kaufmann, M.D has received a total of $154,103 in payments from pharmaceutical and medical device companies, with $18,940 received in 2024. These payments were reported across 74 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($101,298).
As a Medicare-enrolled provider, Kaufmann has provided services to 1,180 Medicare beneficiaries, totaling 1,719 services with total Medicare billing of $152,266. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location New York, NY
- Active Since 01/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1134190291
Products in Payments
- NORTHERA (Drug) $11,762
- VYNDAQEL (Drug) $3,918
- ONPATTRO (Drug) $115.99
- Yupelri (Drug) $80.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in New York
Dr. Stephen Krieger, Md, MD
Neurology — Payments: $1.6M
Neurology $1.6M
Dr. David Dodick, M.d, M.D
Neurology — Payments: $765,174
Neurology $765,174
Dr. David Simpson, M.d, M.D
Neurology — Payments: $638,492
Neurology $638,492
Steven Wolf, Md, MD
Neurology — Payments: $585,108
Neurology $585,108
Dr. Alexander Shtilbans, Md, Ph.d, MD, PH.D
Neurology — Payments: $550,165
Neurology $550,165
Dr. Fred Lublin, M.d, M.D
Neurology — Payments: $549,390
Neurology $549,390